Perfil
Michael D.
Adelman formerly worked at AstraZeneca Pharmaceuticals LP, as Senior Director-Marketing Strategy, Adolor Corp., as Vice President-Marketing & Sales, Cangene Corp., as Vice President-Commercial Operations, and Medexus Pharmaceuticals, Inc., as General Manager-US Operations.
Mr. Adelman received his Masters Business Admin degree from New York University and undergraduate degree from Northeastern University.
Antiguos cargos conocidos de Michael Adelman.
| Empresas | Cargo | Fin |
|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Corporate Officer/Principal | 24/06/2024 |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Corporate Officer/Principal | - |
| CANGENE CORPORATION | Corporate Officer/Principal | - |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Ventas & Marketing | - |
Formación de Michael Adelman.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Cangene Corp.
Cangene Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and sells biopharmaceutical drugs | Health Technology |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
Medexus Pharmaceuticals, Inc.
Medexus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides healthcare products which focuses on therapeutic areas of auto-immune disease and pediatrics | Health Technology |
- Bolsa de valores
- Insiders
- Michael Adelman
















